Diomed Developments Limited

Diomed Developments Limited specialises in topical medical devices for skin care and ear health. Their portfolio includes emollients and dry skin treatments like the Doublebase range (e.g., Doublebase Dry Skin Emollient and Doublebase Emollient Gel), sodium bicarbonate-based cleansers such as Otex Sodium Bicarbonate, ear drops like Otex Olive Oil ear drops, and adhesive removal aids like the 4Head QuickStrip. These products are designed to address skin hydration, irritation, and ear care needs.

Diomed Developments Limited is based in the United Kingdom. As a UK-based manufacturer, their devices fall under the scope of the EU Medical Device Regulations (MDR) if marketed within the European Economic Area. This means their products must comply with MDR requirements, including classification, registration in EUDAMED, and adherence to relevant safety and performance standards.

Diomed Developments Limited’s devices are registered in the EUDAMED database, which is the official European Union database for medical devices. EUDAMED serves as a centralised registry for tracking device manufacturers, authorised representatives, and market surveillance activities under the EU Medical Device Regulations (MDR). This registration ensures transparency and compliance with EU regulatory requirements.

Diomed Developments Limited’s devices are classified as either Class I or Class IIa under the EU Medical Device Regulations. Classification depends on factors like the intended purpose, risk level, and interaction with the body. For example, emollients like Doublebase Once are typically low-risk and fall under Class I, while certain formulations or specialised products (e.g., ear drops) may require additional risk assessments, placing them in Class IIa. This classification determines the regulatory controls and documentation requirements for each device.

Yes, some of Diomed Developments Limited’s devices, such as the Doublebase Once OTC, are formulated for over-the-counter use. Even though these products are intended for self-selection by consumers, they are still classified as medical devices under EU regulations and must meet the same safety and performance standards as prescription-only devices. Their classification (Class I or IIa) is based on risk assessment rather than distribution channel, ensuring patient safety regardless of how the product is accessed.